Tejal Aslesh
8613-114 St
Edmonton, AB, Canada
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Systemic Injection of Antisense Oligos into Spinal Muscular Atrophy (SMA) Mice and Evaluation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
DG9 boosts PMO nuclear uptake and exon skipping to restore dystrophic muscle and cardiac function.
Journal: Nature communications
Published: April 02, 2024
Assessing the Role of Aquaporin 4 in Skeletal Muscle Function.
Journal: International journal of molecular sciences
Published: December 16, 2022
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 15, 2021
eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping.
Journal: Nucleic acids research
Published: March 05, 2021
Restoration of dystrophin expression and correction of Duchenne muscular dystrophy by genome editing.
Journal: Expert opinion on biological therapy
Published: January 06, 2021
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 01, 2020
Development of Antisense Oligonucleotide Gapmers for the Treatment of Huntington's Disease.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 01, 2020
Systemic and ICV Injections of Antisense Oligos into SMA Mice and Evaluation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2018
Nusinersen in the Treatment of Spinal Muscular Atrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2018
Last Updated: 09/26/2026